Status:
COMPLETED
Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this case series is to describe the characteristics, organ dysfunction and support and 2 week outcomes of critically ill patients with nCov infection.
Detailed Description
The 2019 novel-coronavirus (2019-nCov) is the cause of a cluster of unexplained pneumonia that started in Hubei province in China 1. It has manifest into a global health crisis with escalating confirm...
Eligibility Criteria
Inclusion
- admission to ICU
- adult (≥18 years old)
- confirmed case of 2019-nCov infection by 2019-nCov RNA by reverse transcription polymerase chain reaction , isolation in cell culture of 2019-nCov from a clinical specimen or serum antibody to 2019-nCov
Exclusion
- \- none
Key Trial Info
Start Date :
February 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 25 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04285801
Start Date
February 14 2020
End Date
February 25 2020
Last Update
March 10 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamela Youde Nethersole Eastern Hospital
Hong Kong, Hong Kong
2
Prince of Wales Hospital
Hong Kong, Hong Kong
3
Princess Margaret Hospital
Hong Kong, Hong Kong